2nd Quarter - Report

ABBVIE, INC. for ABBVIE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 22, 2013 $470,000 Replaced
2nd Quarter - Amendment Oct 21, 2013 $630,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implementation of Public Law 111-152, The Reconciliation Act of 2010 Implementation of Public Law 112-144, Food and Drug Administration Safety and Innovation Act H.R. 1483, Drug Safety Enhancement Act of 2011S.214, Preserve Access to Affordable Generics Act S.621 Safe Prescribing Act of 2013 Proposals to increase security of US drug distribution supply chain Proposals to improve viral hepatitis screening

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
CHRISTOPHER LEIBUNDGUTH —
ADELE R WITENSTEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S. 621 (113th), H.R. 1483 (113th)

Budget/Appropriations BUD

Implementation of Public Law 112-25, the Budget Control Act of 2011 Funding for State AIDS Drug Assistance programs under Ryan White Care Act Funding for Center for Disease Control Office, Division of Viral Hepatitis

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD New Sr.Counsel House Energy&Commerce Com 98-08
ANDREW KAPLAN New —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Proposals to improve science, technology, engineering and mathematics education

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
ANDREW KAPLAN —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trade issues regarding the Trans-Pacific Partnership Agreement Trade issues regarding the Trans-Atlantic Trade and Investment Partnership Trade issues regarding Trade Promotion Authority

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
ANDREW KAPLAN —
ADELE R WITENSTEIN —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Proposals to reform domestic and international tax structures

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
ANDREW KAPLAN —
CHRISTOPHER LEIBUNDGUTH —
ADELE R WITENSTEIN —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicare Medicare payment proposals

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CATHERINE DRATZ FERGUSON —
JOHN P. FORD —
ANDREW KAPLAN —
ADELE R WITENSTEIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.